Site Selection and Management
Investigator and site selection determines whether a study recruits to plan or falls behind. We know Egypt’s hospitals and investigators, we select them with rigour, and we support them from activation through to the final close-out visit.
Recruitment is where clinical studies most often lose time and budget, and recruitment performance depends on the sites. An experienced investigator with access to the right patients, a dedicated coordinator and a well-prepared pharmacy can carry a study; an unsuitable site can delay an entire programme.
Our site selection and management service brings feasibility, investigator selection, contracting, activation and day-to-day site support under one accountable team. We qualify every site in person, agree evidence-based targets with every investigator, and keep each site trained, supported and on schedule for the duration of the study.
For multinational studies, we serve as your local partner in Egypt, applying the sponsor’s global standards while managing the institutional relationships, approvals and logistics that call for an experienced local CRO.

End-to-end site services, from feasibility to close-out
We assume full responsibility for your investigational sites: identifying them, preparing them, supporting them and sustaining their performance throughout the study.
Country and site feasibility
Structured questionnaires, investigator interviews and evidence on patient availability, competing studies and approval timelines, ensuring recruitment projections rest on data rather than assumption.
Principal investigator selection
Investigators selected for their patient access, research experience, GCP training and demonstrated commitment, rather than reputation alone.
Site qualification visits
On-site assessment of personnel, facilities, equipment, pharmacy and storage, laboratory capability and documentation practices before any recommendation is made.
Site contracts and budgets
Clinical trial agreements and transparent, fair-market site budgets negotiated with investigators and institutions, with investigator payments administered throughout the study.
Regulatory and ethics documentation
Investigator CVs, GCP certificates, delegation logs, financial disclosures and institutional approvals collected and verified for each site’s submission.
Site initiation and training
Initiation visits that equip investigators, coordinators and pharmacists with a thorough understanding of the protocol, GCP, safety reporting, Insight EDC and investigational product handling.
Recruitment and retention support
Site-level recruitment strategies, pre-screening logs, referral pathways, approved participant materials and practical measures to sustain participant retention.
Study coordination support
Where a site requires additional capacity, our team assists with scheduling, data entry and document management, allowing investigators to concentrate on their participants.
Site performance management
Continuous oversight of recruitment, data quality, deviations and outstanding actions at every site, with prompt intervention when performance declines.
Investigator site file management
Investigator site files established, reconciled and maintained in an inspection-ready state from activation to archiving.
Site close-out
Final reconciliation of documents, data and investigational product, formal close-out visits, and notification of the ethics committees and the authority.
A structured pathway to high-performing sites
- 01
Feasibility assessment
We approach candidate investigators, share the synopsis under confidentiality, and gather evidence on eligible patients, capacity and competing research.
- 02
Shortlisting and qualification
We visit the most promising sites, evaluate them against the protocol’s requirements and recommend a final selection with a realistic recruitment target for each.
- 03
Contracts and approvals
Agreements, budgets and institutional approvals are finalised while each site’s documentation is prepared for ethics and authority submission.
- 04
Site readiness
Investigational product, laboratory kits, equipment and study materials are delivered and verified, and Insight EDC access is established for the site team.
- 05
Initiation visit
We train the entire site team and confirm that every prerequisite is in place before the site is activated for recruitment.
- 06
Ongoing support
Monitors and site managers maintain close contact, resolve operational issues promptly and sustain the momentum of recruitment and data entry.
- 07
Performance review
Site performance is reported to you regularly, and we agree corrective measures, additional support or supplementary sites whenever recruitment is at risk.
- 08
Close-out and archiving
Each site is closed formally, with all documentation reconciled and archived for the required retention period.
Established relationships that accelerate recruitment
Our long-standing presence in Egyptian clinical research has built trusted partnerships with hospitals, universities and research centres, and a well-informed view of which sites consistently deliver.
- 01
Evidence-based recruitment targets
Targets agreed with each investigator and grounded in verified patient numbers rather than optimistic projections.
- 02
Accelerated site activation
Familiarity with each institution’s contracting and approval procedures allows us to run them in parallel and shorten timelines.
- 03
A single point of accountability
Sites and sponsors alike always know whom to contact, and receive a prompt, informed response.
- 04
Inspection-ready sites
Sites trained and supported to meet Egyptian Drug Authority and international GCP expectations at any visit.
More from our clinical research team
Clinical Studies Management
Our flagship full-service offering, from feasibility to the final clinical study report.
Protocol Development
Protocols, consent forms and essential study documents designed for approval and flawless execution.
Clinical Monitoring
Risk-based monitoring to local and global multinational standards.
Data Management and Biostatistics
Validated data on Insight EDC and statistical analysis that withstands scrutiny.
Medical Writing
Clinical, regulatory and publication documents of the highest scientific standard.
